Intestinal Epithelial Cell-derived Osteopontin Protects Against Metabolic Dysfunction-associated Steatohepatitis by

Hui Han1, Jeongwoo Park2, Rui Zhang3

  • 1Department of Pathology, University of Illinois Chicago, Chicago, Illinois; Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.

Summary

Intestinal epithelial osteopontin (OPN) protects against metabolic dysfunction-associated steatohepatitis (MASH). Loss of OPN in these cells worsens MASH by altering bile acids and the gut microbiome.